Botulinum toxin: what it is and why people call it Botox

Botox is a brand. Botulinum toxin is the substance.

Confusing the two is the same habit as calling every tissue a Kleenex or every adhesive bandage a Band-Aid: the first brand to arrive became the generic name. Botox® is one commercial brand of botulinum toxin type A, and several others are registered in Brazil, with slightly different formulations and behaviour.

In the treatment room this matters little to the person receiving it — they all do essentially the same thing. But it is worth knowing that when someone says "I get Botox", they are saying "I have botulinum toxin injected", and the product used could be any of the registered ones.

What botulinum toxin is

It is a protein produced by the bacterium Clostridium botulinum. In the quantity and route of exposure typical of food poisoning, that same protein causes botulism — a severe paralysis.

This tends to alarm people, and the explanation is the usual one in pharmacology: the dose separates the poison from the medicine. The amount used in facial aesthetic treatment is thousands of times smaller than what would be needed for a systemic effect, and it is purified, standardised in units and injected locally into the target muscle.

The same reasoning applies to plenty of everyday medications that are toxic at a high dose.

How botulinum toxin acts on muscle

For a muscle to contract, the nerve has to release a neurotransmitter — acetylcholine — at the junction between nerve and muscle. The toxin blocks that release.

Without the signal, the muscle contracts with less force. The skin that was being folded by that movement stops folding, and the expression line softens.

Three consequences of this are worth understanding:

• The effect is local. The toxin acts where it was injected and in the millimetres around it. In aesthetic use it does not circulate through the body.
• The effect is temporary. The body rebuilds the nerve endings over months, and function returns in full.
• The effect is dose-dependent. A lower dose weakens the muscle; a higher dose immobilises it. That is the difference between a face with softened expression and a frozen one.

What botulinum toxin is used for

In facial aesthetics

It treats dynamic wrinkles — the ones that appear with movement. Forehead, glabella, crow's feet, gummy smile, and the contour of the lower third via the masseter.

It does not treat deep static wrinkles, the ones already etched with the face at rest. That is a limitation of mechanism, not of dose: the toxin acts on muscle, and a set line belongs to the skin.

In therapeutic indications

Medical use of the toxin predates the aesthetic one and is broader than most people imagine: chronic migraine, hyperhidrosis, muscle spasms, dystonias, strabismus, overactive bladder, among others.

At the interface with dentistry, the most relevant functional use is bruxism — injecting the masseter reduces clenching force, with an effect on muscle pain and tooth wear. The slimming of the facial contour, in that case, is a consequence of the functional treatment.

What the risks of botulinum toxin are

The most common events are local and short-lived: a small bruise at the injection point, tenderness, a mild headache in the first few days.

The unwanted effects that bother people most come from diffusion into neighbouring muscles or from poorly chosen points:

• Drooping eyelid or brow
• Asymmetry of expression
• An altered smile, when the injection reaches perioral musculature
• A motionless face, from more product than needed

All are temporary. All depend more on technique and anatomical knowledge than on the product. And none is reversible — unlike filler, toxin has no antidote, and the treatment is time.

Contraindications

Neuromuscular diseases such as myasthenia gravis, Eaton-Lambert syndrome and amyotrophic lateral sclerosis; allergy to components of the formulation; active infection at the site; pregnancy and breastfeeding.

Does the toxin stay in the body?

It does not accumulate. The protein is broken down by the body, and what marks the end of the effect is the rebuilding of the nerve endings — not the substance "leaving".

What can accumulate, in a minority of people, are neutralising antibodies, when sessions are very frequent or involve repeated high doses. That is the reason for the minimum three-month interval between sessions.

Botulinum toxin and the liver

There is no mechanism by which toxin used in facial aesthetics would cause liver damage. The dose is minimal, the action is local at the neuromuscular junction, and no meaningful hepatic metabolism is involved.

The question circulates widely and has no basis — but liver conditions, like any health condition, belong in the medical history.

What the choice of product changes

Every toxin registered with Anvisa, the Brazilian health regulator, for aesthetic use is botulinum toxin type A. The differences between brands lie in the formulation — the presence or absence of accessory proteins, units of measurement that are not interchangeable between products, and small variations in onset and duration of effect.

For the person receiving it, this is secondary. The choice of who injects weighs incomparably more than the choice of brand, because dose, points and reading of the musculature define the result.

What is worth checking is the product's registration and the integrity of the vial — not the brand.

When we advise against it

• When the complaint is a deep static wrinkle. The toxin will not erase it, and raising the dose to try produces a motionless face with the line still there.
• Less than three months since the previous session, because of the resistance risk.
• When the request is immobility. It is not a therapeutic goal, and it usually comes from expectations formed on edited images.
• In someone who has never been treated, doing every area of the upper third at full dose in the same session. Starting conservative leaves room to adjust; starting full does not.
• Pregnancy and breastfeeding, and in the neuromuscular diseases listed above.

Frequently asked questions

What is the difference between Botox and botulinum toxin?

None, in practice. Botox® is one of the commercial brands of botulinum toxin type A, and the name became generic in everyday use.

How much does botulinum toxin cost?

It varies with the area treated and the number of units. Charging per unit and charging per area are different models, and it is worth knowing which one is being used before comparing quotes.

Is botulinum toxin dangerous?

At the dose and route used in facial aesthetics, the safety profile is well established, with decades of clinical use. The relevant risks are tied to technique and to the qualification of whoever injects, not to the substance.

Is there a minimum age?

There is no universal number. The criterion is the indication: dynamic lines already marked and tending to become static. Treating someone with no lines at all prevents nothing.

Can someone with a neurological condition have it?

Neuromuscular diseases are a contraindication. Other neurological conditions require individual assessment with the doctor following the case.